Maria Rovira-Rigau

Zeb1 in Stromal Myofibroblasts Promotes Kras-Driven Development of Pancreatic Cancer.

F. Campbell, X. Molero, A. Castells, 2018, Cancer research.

Oligopeptide-modified poly(beta-amino ester)s-coated AdNuPARmE1A: Boosting the efficacy of intravenously administered therapeutic adenoviruses

L. Albertazzi, A. Cascante, S. Borrós, 2020, Theranostics.

Patient-derived pancreatic tumour organoids identify therapeutic responses to oncolytic adenoviruses

H. Clevers, H. Begthel, S. Boj, 2020, EBioMedicine.

MiR-93 is related to poor prognosis in pancreatic cancer and promotes tumor progression by targeting microtubule dynamics

J. Iovanna, M. Vila-Casadesús, J. Lozano, 2020, Oncogenesis.

Translational reprogramming in tumour cells can generate oncoselectivity in viral therapies

R. Méndez, E. Villanueva, C. Fillat, 2017, Nature Communications.

A genetic fiber modification to achieve matrix-metalloprotease-activated infectivity of oncolytic adenovirus.

R. Alemany, D. Andreu, E. Vaquero, 2014, Journal of controlled release : official journal of the Controlled Release Society.

Bioselection Reveals miR-99b and miR-485 as Enhancers of Adenoviral Oncolysis in Pancreatic Cancer.

R. Alemany, M. A. Marín, M. Gironella, 2019, Molecular therapy : the journal of the American Society of Gene Therapy.

Implications of MicroRNAs in Oncolytic Virotherapy

C. Fillat, Xavier Bofill-De Ros, Maria Rovira-Rigau, 2017, Front. Oncol..